About Immunoassay Analyzers
Immunoassay analyzers perform biochemical tests to detect antibodies that are specific proteins produced by the body to fight antigens. In clinical laboratories, these analyzers are used to detect a variety of substances, including infectious diseases, cardiac markers, endocrine hormone testing, proteins, and for viral or bacterial determination, from a patient’s biological sample such as blood or body fluid.
Technavio’s analysts forecast the clinical immunoassay analyzer market in the US to grow at a CAGR of 6.04% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the clinical immunoassay analyzer market in the US for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of immunoassay analyzers, which are used in clinical laboratories to detect infectious diseases such as human immunodeficiency virus (HIV) and hepatitis, cancer, therapeutic drug monitoring, and others Technavio's report, Clinical Immunoassay Analyzer Market in the US 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Technavio Announces the Publication of its Research Report – Clinical Immunoassay Analyzer Market in the US 2016-2020
Technavio recognizes the following companies as the key players in the Clinical Immunoassay Analyzer Market in the US: Abbott Diagnostics, Beckman Coulter, bioMérieux, Roche Diagnostics, and Siemens Healthcare Diagnostics.
Other Prominent Vendors in the market are: Affimetrix, Boditech Med, DiaSorin, DRG International, Enzo Life Sciences, EMD Millipore, Immunodiagnostics System, Inova Diagnostics, Meso Scale Discovery, Nova Century Scientific, Olympus, Quidel, Radiometer, Randox Laboratories, SDIX, Tecan, and Thermo Fisher Scientific.
Commenting on the report, an analyst from Technavio’s team said: “An emerging trend to not is the use of paper-based electrochemical immunoassay devices. Researchers are working to develop paper-based electrochemical immunoassay devices that can be used for POCT and diagnosis. These tests are inexpensive and can provide results quickly. The paper patterning cost to use it as a substrate can cost as low as $0.01 per device.”
According to the report, a key driver of market growth is the rising demand for next-generation immunodiagnostics. Next-generation immunodiagnostic equipment are being designed to address the needs of modern clinical laboratories. These instruments provide high-quality, reliable test results for patients and clinicians. Manufacturers enhance the hardware by innovating technology to improve workflow and turnaround time.
Further, the report states that one challenge that will impact the growth of this market is the high cost of upgrading.
Abbott Diagnostics, Beckman Coulter, bioMérieux, Roche Diagnostics, Siemens Healthcare Diagnostics, Affimetrix, Boditech Med, DiaSorin, DRG International, Enzo Life Sciences, EMD Millipore, Immunodiagnostics System, Inova Diagnostics, Meso Scale Discovery, Nova Century Scientific, Olympus, Quidel, Radiometer, Randox Laboratories, SDIX, Tecan, Thermo Fisher Scientific.